| abstract |
The present invention relates to new thiazolyl-dihydro-indazoles of general formula (I) n n n n n n n n n n wherein the groups R 1 , R 2 and R 3 have the meanings given in the claims and specification, the tautomers, racemates, enantiomers, diastereomers and the mixtures thereof, and optionally the pharmacologically acceptable acid addition salts, solvates and hydrates thereof, and processes for preparing these thiazolyl-dihydro-indazoles and the use thereof as pharmaceutical compositions. |